arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

DEXCOM INC

DXCM
$84.47 ▼ -4.00 (-4.53%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
87
Health
Excellent
Bullish
auto_awesome

Analytical Summary

DEXCOM INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $33.0B
Dividend Yield —
Revenue Growth 15.6% ↗
Op. Margin 19.6% ↗
ROIC 25.5% ↗
FCF / Share $2.76 ↗
Trailing P/E 39.5x
Price / Book 11.8x
FCF Yield 3.3%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$4.66B
↑ +15.6% —
Net Income Profit after all expenses
$836.30M
↑ +45.1% —
Operating Margin Operating profit as % of sales
19.6%
↑ +31.5% 74th
FCF / Share Free cash flow per share
$2.76
↑ +72.3% —
Long-Term Debt Long-term obligations
$4.60M
↓ -32.4% —
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
80
Returns ↑
93
Financial Health ↑
94
Cash Quality ↑
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 69 quarters